Table 1 CCT of Hemorrhagic and non-Hemorrhagic Hemisphere in Different Demographic Groups.

From: Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome

 

CCT (95% CI)

P value

OR

Hemorrhagic (s)

non-Hemorrhagic (s)

Total patients

  CFCT (ICA)

4.52 (4.22–4.82)

5.41 (5.14–5.68)

<0.001

0.201

  CVCT (ICA)

12.02 (11.17–12.88)

10.64 (10.28–11.01)

<0.001

1.765

  CTCT (ICA)

16.55 (15.50–17.59)

16.06 (15.52–16.60)

0.562

 

Male

  CFCT (ICA)

4.42 (4.06–4.78)

5.69 (5.31–6.07)

0.005

0.120

  CVCT (ICA)

12.29 (11.10–13.47)

10.67 (10.22–11.13)

0.016

1.813

  CTCT (ICA)

16.70 (15.45–17.95)

16.36 (15.68–17.04)

0.280

 

Female

  CFCT (ICA)

4.59 (4.13–5.06)

5.12 (4.75-5.50)

0.001

0.260

  CVCT (ICA)

11.84 (10.57–13.10)

10.61 (10.04–11.19)

0.008

1.547

  CTCT (ICA)

16.43 (14.79–18.07)

15.75 (14.91–16.59)

0.740

 

Adults (≥18 y)

  CFCT (ICA)

4.57 (4.26–4.88)

5.46 (5.17–5.75)

<0.001

0.238

  CVCT (ICA)

11.89 (11.00–12.77)

10.71 (10.31–11.11)

<0.001

1.583

  CTCT (ICA)

16.45 (15.35–17.55)

16.17 (15.58–16.76)

0.525

 

Children (<18 y)

  CFCT (ICA)

3.90 (1.95–5.85)

5.18 (4.46–5.91)

0.052

 

  CVCT (ICA)

13.87 (7.35–20.39)

10.34 (9.47–11.21)

0.251

 

  CTCT (ICA)

17.77 (9.86–25.68)

15.52 (14.19–16.85)

0.052

 

Suzuki 1–2

  CFCT (ICA)

4.10 (3.55–4.65)

4.05 (3.77–4.33)

0.914

 

  CVCT (ICA)

11.42 (10.01–12.83)

10.13 (9.44–10.81)

0.362

 

  CTCT (ICA)

15.52 (14.18–16.86)

14.18 (13.33–15.02)

0.475

 

Suzuki 3–4

  CFCT (ICA)

4.57 (4.19–4.96)

5.80 (5.46–6.14)

<0.001

0.097

  CVCT (ICA)

12.70 (11.65–13.75)

10.92 (10.40–11.45)

<0.001

2.404

  CTCT (ICA)

17.27 (15.92–18.63)

16.74 (15.97–17.50)

0.226

 

Suzuki 5

  CFCT (ICA)

4.69 (3.81–5.57)

6.55 (5.92–7.19)

0.041

0.336

  CVCT (ICA)

10.46 (7.90–13.02)

10.64 (9.91–11.38)

0.156

 

  CTCT (ICA)

15.15 (12.06–18.25)

17.20 (16.23–18.16)

0.156

 
  1. Logistic regression (multivariate analysis) was used to analyze the differences of cerebral circulation time between hemorrhagic and non-hemorrhagic MMD in different demographic groups.